Glumetza FDA Approval History
FDA Approved: Yes (First approved June 3, 2005)
Brand name: Glumetza
Generic name: metformin extended release
Dosage form: Tablets
Company: Biovail Corporation/Depomed, Inc.
Treatment for: Diabetes, Type 2
Glumetza (metformin extended-release) is a once-daily oral antihyperglycemic formulation indicated for the treatment of type 2 diabetes.
Development timeline for Glumetza
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.